About: Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 23 December 2004

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2004 (fr) наукова стаття, опублікована в грудні 2004 (uk) im Dezember 2004 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2004 (ast) scientific article published on 23 December 2004 (en)
publication date	wds:Q81192861-5B11DCFD-7E97-4213-9D08-2957A1E73228
publication date	2004-12-23 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q81192861-226DC8DD-30EF-4E89-8CB2-E858C90FA966
language of work or name	English
exact match	wds:Q81192861-02DB621C-C676-4245-9FD7-C1E410141ADC
exact match	https://scigraph.springernature.com/pub.10.1007/s00432-004-0635-y
cites work	wds:Q81192861-096B538B-47FD-4E4E-8D7F-3B11B4D49D45 wds:Q81192861-2B22C4AA-E6E0-4501-98DB-F44B2CD10D59 wds:Q81192861-41A374FB-567C-417A-9A22-0D9F4077FED7 wds:Q81192861-434651A1-DCEC-4711-BAE2-C3A6E8B1C24A wds:Q81192861-46BB86E0-27E6-4931-8EC7-B82B1AEEF54B wds:Q81192861-4DC183F9-01A5-4E02-A678-68713AD310BE wds:Q81192861-503811FF-F1C0-4FA5-9751-211ECA164119 wds:Q81192861-5DDC181D-6CDE-46AD-994A-DDC3FAE0E816 wds:Q81192861-70E94A4A-AC92-4338-A496-E103BEB91DBB wds:Q81192861-7111F40B-E49B-4290-9450-358DEDEA80E4 wds:Q81192861-7C1F0AF6-5F7C-4370-9BB2-4D3184D61279 wds:Q81192861-831B6179-F6D7-4155-A6AA-C2436C7AA373 wds:Q81192861-886DC7F6-EB4C-41D7-A4A5-490D8CE49656 wds:Q81192861-8C0356E5-8955-408E-996B-BE73AE1D7CD7 wds:Q81192861-8C7719B0-6DB8-493E-A307-897D83F9999C wds:Q81192861-946D466B-A5D8-4F47-936D-A194BAA9F90D wds:Q81192861-958AB685-A4EC-40EC-A85E-DA30BA8BD425 wds:Q81192861-AA34A437-71DF-4F63-BF32-0A2BF1313E31 wds:Q81192861-B107B4D5-95E3-4028-B6E3-733D97632262 wds:Q81192861-B94CDC72-2ED0-4382-ACD4-7FA54E488C79 wds:Q81192861-C1540008-250F-4757-A7F7-C203CC3E0E8D wds:Q81192861-E5A7666A-DACB-421A-8074-7B454C645792 wds:Q81192861-EC8B4594-AC78-4018-ADFA-C2EB2A908862
cites work	Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapy A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma Circulating peripheral blood plasma cells as a prognostic indicator in patients with primary systemic amyloidosis Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome. Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC). Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells. Bone marrow angiogenesis and circulating plasma cells in multiple myeloma Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV).
author name string	wds:Q81192861-14924D5E-BE9D-4089-BA50-E8B5C871CAF4 wds:Q81192861-429C579E-930C-4DFF-A997-4CBF2191B7CD wds:Q81192861-9FC3AE1B-D2A0-46FD-BDF7-0D3750A58029
author name string	Hans-Georg Kopp Lothar Kanz Wichard Vogel
rdfs:label	Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation (en) Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation (nl)
skos:prefLabel	Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation (en) Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation (nl)
name	Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation (en) Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation (nl)
author	wds:Q81192861-4A9B99B1-D84E-4114-B83E-D9D2AC4227BC
author	Hermann Einsele
title	wds:Q81192861-0EFDF626-1AE4-4F11-8696-2557AE917DEB
title	Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation (en)
page(s)	wds:Q81192861-A4CB14B6-495D-4132-8DD9-7B50B4A8E0F1
page(s)	214-218
instance of	wds:Q81192861-59ACE69C-A955-40EE-8472-CDF10FA7EEE8
instance of	scholarly article
main subject	wds:Q81192861-9CE05A2B-EEB3-41E0-9202-829C3DA0A0A6 wds:Q81192861-F52C68D5-B367-427B-9902-F912BF3B51CB
main subject	multiple myeloma stem cell transplantation
PubMed ID	wds:Q81192861-D6BD2917-8316-4C2C-866C-9CCB0A48C828
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15616828
PubMed ID	15616828
published in	wds:Q81192861-C8A01B28-55F9-483B-B14B-33B284E79FEE
published in	Journal of Cancer Research and Clinical Oncology
issue	wds:Q81192861-6777990C-FDBB-494A-8681-660C40969DFE
volume	wds:Q81192861-D4D91EF3-4EBE-4E7D-A3F8-208779DA6838
issue	4
volume	131
number of pages	wds:Q81192861-C772717E-4AFA-46A1-8C01-6591A753000E
number of pages	5 (xsd:decimal)
DOI	wds:Q81192861-C799AD23-B2DB-471D-B78D-B24DE32733DB
DOI	http://dx.doi.org/10.1007/S00432-004-0635-Y
DOI	10.1007/S00432-004-0635-Y
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q81192861
is cites work of	Growth control of multiple myeloma cells through inhibition of glycogen synthase kinase-3 Viral purging of haematological autografts: should we sneeze on the graft?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software